U.S. flag

An official website of the United States government

NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys) AND not specified

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Feb 3, 2026
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000212953.20

Allele description [Variation Report for NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)]

NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)

Genes:
RAD51D:RAD51 paralog D [Gene - OMIM - HGNC]
RAD51L3-RFFL:RAD51L3-RFFL readthrough [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
17q12
Genomic location:
Preferred name:
NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)
Other names:
p.S46C:TCT>TGT
HGVS:
  • NC_000017.11:g.35119118G>C
  • NG_031858.1:g.5752C>G
  • NG_054719.1:g.2540G>C
  • NM_001142571.2:c.137C>G
  • NM_002878.4:c.137C>GMANE SELECT
  • NM_133629.3:c.137C>G
  • NP_001136043.1:p.Ser46Cys
  • NP_002869.3:p.Ser46Cys
  • NP_002869.3:p.Ser46Cys
  • NP_598332.1:p.Ser46Cys
  • LRG_516t1:c.137C>G
  • LRG_516:g.5752C>G
  • LRG_516p1:p.Ser46Cys
  • NC_000017.10:g.33446137G>C
  • NM_002878.3:c.137C>G
  • NR_037711.2:n.282C>G
  • NR_037712.2:n.282C>G
  • p.S46C
Protein change:
S46C
Links:
dbSNP: rs587780102
Molecular consequence:
  • NM_001142571.2:c.137C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002878.4:c.137C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133629.3:c.137C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_037711.2:n.282C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_037712.2:n.282C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000604997ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Uncertain significance
(Nov 2, 2016)
germlineclinical testing

Citation Link,

SCV002760915Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Dec 29, 2025)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV002819352Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 3, 2026)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Germline mutations in RAD51D confer susceptibility to ovarian cancer.

Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, et al.

Nat Genet. 2011 Aug 7;43(9):879-882. doi: 10.1038/ng.893.

PubMed [citation]
PMID:
21822267
PMCID:
PMC4845885
See all PubMed Citations (10)

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000604997.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV002760915.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002819352.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

Variant summary: RAD51D c.137C>G (p.Ser46Cys) results in a non-conservative amino acid change located in the RAD51D, N-terminal domain (IPR048943) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 7.6e-05 in 251312 control chromosomes. This frequency is not significantly higher than estimated for disease-causing variants in RAD51D, allowing no conclusion about variant significance. c.137C>G has been observed in individuals affected with Breast, Ovarian and Colorectal Cancer without clear evidence for causality (Alenezi_2022, Kraus_2017, Wickramanayake_2012, Loveday_2011, Weren_2015, Velazquez_2020, Guindalini_2022, de Oliveira_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. Co-occurrences with other pathogenic variant(s) have been reported (MSH2 c.2459-1G>C), providing supporting evidence for a benign role. At least one publication reports experimental evidence evaluating an impact on protein function and the data suggests impaired homologous recombination functionality (Alenezi_2022). The following publications have been ascertained in the context of this evaluation (PMID: 35565380, 33630411, 35264596, 27616075, 21822267, 32522261, 25938944, 22986143, 35534704). ClinVar contains an entry for this variant (Variation ID: 127882). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 9, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search